FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

34555411000001104: Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104563501000001116 Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111384201000001111 Mysimba 8mg/90mg modified-release tablets (Orexigen Therapeutics Ireland Ltd) 112 tablet 4 x 28 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Is a Naltrexone 8mg / Bupropion 90mg modified-release tablets 112 tablet true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has AMP Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Naltrexone hydrochloride true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has specific active ingredient Bupropion hydrochloride true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bupropion true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naltrexone true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has basis of strength substance Bupropion true Inferred relationship Existential restriction modifier
Mysimba 8mg/90mg modified-release tablets (Consilient Health Ltd) 112 tablet 4 x 28 tablets Has basis of strength substance Naltrexone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start